Evidence map›Paper›PMID 30914256›Full record

ArticleActa biomaterialia2019

An in vitro and in vivo comparison of cartilage growth in chondrocyte-laden matrix metalloproteinase-sensitive poly(ethylene glycol) hydrogels with localized transforming growth factor β3.

Margaret C Schneider, Stanley Chu, Mark A Randolph, Stephanie J Bryant

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 58 citations in OpenAlex.

  1. A practical toolbox for modelling fibrosis in vitro.Nature biomedical engineering · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Effects of TGF-β3 on meniscus repair using human amniotic epithelial cells.Journal of orthopaedic surgery and research · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Margaret C SchneiderDepartment of Chemical and Biological Engineering, 3415 Colorado Ave, University of Colorado, Boulder, CO 80309-0596, United States. Electronic address: Margaret.Schneider@colorado.edu.
Stanley ChuDepartment of Chemical and Biological Engineering, 3415 Colorado Ave, University of Colorado, Boulder, CO 80309-0596, United States. Electronic address: Stanley.Chu@colorado.edu.
Mark A RandolphLaboratory of Musculoskeletal Tissue Engineering, Massachusetts General Hospital, Boston, MA 021143, United States. Electronic address: marandolph@partners.org.
Stephanie J BryantDepartment of Chemical and Biological Engineering, 3415 Colorado Ave, University of Colorado, Boulder, CO 80309-0596, United States; Materials Science and Engineering Program, University of Colorado, 3415 Colorado Ave, Boulder, CO 80309-0596, United States; Biofrontiers Institute, University of Colorado, 3415 Colorado Ave, Boulder, CO 80309-0596, United States. Electronic address: stephanie.bryant@colorado.edu.
University of Colorado Boulder · USMassachusetts General Hospital · US

Funding

Personalizing Matrix Assisted Autologous Chondrocyte ImplantationR01AR065441 · NIAMS · UNIVERSITY OF COLORADO · PI BRYANT, STEPHANIE J · 2013 to 2017
$1.5M
NIAMS NIH HHS R01 AR065441
6 · The paper itself

Abstract

While matrix-assisted autologous chondrocyte implantation has emerged as a promising therapy to treat focal chondral defects, matrices that support regeneration of hyaline cartilage remain challenging. The goal of this work was to investigate the potential of a matrix metalloproteinase (MMP)-sensitive poly(ethylene glycol) (PEG) hydrogel containing the tethered growth factor, transforming growth factor β3 (TGF-β3), and compare cartilage regeneration in vitro and in vivo. The in vitro environment comprised chemically-defined medium while the in vivo environment utilized the subcutaneous implant model in athymic mice. Porcine chondrocytes were isolated and expanded in 2D culture for 10 days prior to encapsulation. The presence of tethered TGF-β3 reduced cell spreading. Chondrocyte-laden hydrogels were analyzed for total sulfated glycosaminoglycan and collagen contents, MMP activity, and spatial deposition of aggrecan, decorin, biglycan, and collagens type II and I. The total amount of extracellular matrix (ECM) deposited in the hydrogel constructs was similar in vitro and in vivo. However, the in vitro environment was not able to support long-term culture up to 64 days of the engineered cartilage leading to the eventual breakdown of aggrecan. The in vivo environment, on the other hand, led to more elaborate ECM, which correlated with higher MMP activity, and an overall higher quality of engineered tissue that was rich in aggrecan, decorin, biglycan and collagen type II with minimal collagen type I. Overall, the MMP-sensitive PEG hydrogel containing tethered TGF-β3 is a promising matrix for hyaline cartilage regeneration in vivo. STATEMENT OF SIGNIFICANCE: Regenerating hyaline cartilage remains a significant clinical challenge. The resultant repair tissue is often fibrocartilage, which long-term cannot be sustained. The goal of this study was to investigate the potential of a synthetic hydrogel matrix containing peptide crosslinks that can be degraded by enzymes secreted by encapsulated cartilage cells (i.e., chondrocytes) and tethered growth factors, specifically TGF-β3, to provide localized chondrogenic cues to the cells. This hydrogel led to hyaline cartilage-like tissue growth in vitro and in vivo, with minimal formation of fibrocartilage. However, the tissue formed in vitro, could not be maintained long-term. In vivo this hydrogel shows great promise as a potential matrix for use in regenerating hyaline cartilage.

Indexed as

AnimalsBiocompatible MaterialsCells, CulturedChondrocytesChondrogenesisCollagenCompressive StrengthDrug Delivery SystemsDrug LiberationExtracellular MatrixFibrocartilageGlycosaminoglycansHumansHyaline CartilageHydrogelsMatrix MetalloproteinasesA73025Biocompatible MaterialsCollagenGlycosaminoglycansHydrogelsMatrix MetalloproteinasesPolyethylene GlycolsTransforming Growth Factor beta3Cartilage extracellular matrixChondrocyteIn vitroIn vivoPoly(ethylene glycol) hydrogelTransforming growth factor beta 3

Identifiers

PMID30914256
PMCPMC6980342
OpenAlexW2931899299

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.